secwatch.observer — SEC 8-K summary
======================================

Issuer:     CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
CIK:        0001801170
Form:       8-K
Filed at:   2023-12-27T23:59:59+00:00
Accession:  0001801170-23-000126
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Clover Health appoints Terrence Ronan as Interim CFO effective Jan 27, 2024
---------------------------------------------------------------------------

- Ronan will join as Interim SVP of Finance on Jan 2, 2024, then become Interim CFO on Jan 27, 2024 after Scott Leffler's departure.
- Ronan is a certified public accountant (inactive) with prior CFO roles at Purdue Pharma L.P. and Atlantic Power Corporation.
- Company will pay AP Services, LLC (AlixPartners subsidiary) a monthly fee of $195,000 for Ronan's services as Interim CFO.
- No family relationships or material interests in transactions disclosed between Ronan and any director or executive officer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1801170/000180117023000126/0001801170-23-000126-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1801170/000180117023000126/clov-20231222.htm
  HTML page:      https://secwatch.observer/filing/0001801170-23-000126

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer